Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Vanda Pharmaceuticals Inc. (VNDA)

3.7900 -0.2600 (-6.42%)
At close: October 30 at 4:00:01 PM EDT
3.8100 +0.0200 (+0.53%)
After hours: October 30 at 7:10:17 PM EDT
Trade VNDA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
229,278
216,105
198,772
192,640
254,382
Cost of Revenue
14,704
13,044
11,314
14,796
24,282
Gross Profit
214,574
203,061
187,458
177,844
230,100
Operating Expense
392,481
354,229
228,118
191,796
223,771
Operating Income
-177,907
-151,168
-40,660
-13,952
6,329
Other Income Expense
6,709
12,521
17,739
20,291
4,971
Pretax Income
-171,198
-138,647
-22,921
6,339
11,300
Tax Provision
103,631
81,827
-4,021
3,830
5,025
Net Income Common Stockholders
-274,829
-220,474
-18,900
2,509
6,275
Diluted NI Available to Com Stockholders
-274,829
-220,474
-18,900
2,509
6,275
Basic EPS
-4.62
-3.74
-0.33
0.04
0.11
Diluted EPS
-4.62
-3.74
-0.33
0.04
0.11
Basic Average Shares
59,815.8950
58,930.1570
58,149.0870
57,380.9750
56,461.8770
Diluted Average Shares
59,815.8950
58,930.1570
58,149.0870
57,557.9110
56,983.1710
Total Operating Income as Reported
-177,907
-151,168
-40,660
-13,952
6,329
Total Expenses
407,185
367,273
239,432
206,592
248,053
Net Income from Continuing & Discontinued Operation
-274,829
-220,474
-18,900
2,509
6,275
Normalized Income
-274,829
-220,474
-18,900
2,509
6,275
EBIT
-177,907
-151,168
-40,660
-13,952
6,329
EBITDA
-170,194
-139,251
-30,861
-9,618
9,062
Reconciled Cost of Revenue
14,704
8,134
8,788
12,552
23,065
Reconciled Depreciation
7,713
11,917
9,799
4,334
2,733
Net Income from Continuing Operation Net Minority Interest
-274,829
-220,474
-18,900
2,509
6,275
Normalized EBITDA
-170,194
-139,251
-30,861
-9,618
9,062
Tax Rate for Calcs
0.0004
0.0003
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 4/12/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: